Vetoquinol: 2017 Calendar of Financial Communication

Regulatory News:

Vetoquinol (Paris:VETO) published its calendar of financial communication for 2017.

Next update: 2016 Annual revenues – January 23, 2017 after market close

About Vetoquinol
Vetoquinol is a leading global player in the animal health sector serving both the livestock (cattle and pigs) and pet (dogs and cats) markets.
An independent pure player, VETOQUINOL designs, develops and sells veterinary drugs and non-medicinal products in Europe, the Americas and the Asia Pacific region.
Since its foundation in 1933, Vetoquinol has pursued a strategy combining innovation with geographical diversification. The Group's hybrid growth is driven by the reinforcement of its product portfolio coupled with acquisitions in high potential growth markets. Vetoquinol employs over 2,000 people.
Vetoquinol has been listed on NYSE Euronext Paris since 2006 (symbol: VETO).

At the 2016 Gaia-Index, best small to medium-sized companies for its commitment to Environmental, Social and Corporate Governance (ESG).

For further information, go to: www.vetoquinol.com.

Our business: animals. Our advantage: people.

VETOQUINOL – 34 rue du Chêne Sainte Anne - Magny-Vernois – 70204 Lure Cedex – France
www.vetoquinol.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20161212005003/en/